CARL
LIVE

Serial Number

79231519

Owner

ResuSciTec GmbH

Attorney

Alan E. Schiavelli

Filing Date

Aug 3, 2017

Add to watchlist:

No watchlists yet
View on USPTO

CARL Trademark

Serial Number: 79231519 • Registration: 6044431

CARL is a trademark filed by ResuSciTec GmbH on August 3, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

ResuSciTec GmbH (17 trademarks)

Engesserstr. 4a

Entity Type: 16

Trademark Details

Filing Date

August 3, 2017

Registration Date

May 5, 2020

Published for Opposition

February 18, 2020

Goods & Services

Physical therapy equipment for cardio training being ergometer, bicycle ergometer, indoor cycles, treadmill, crosstrainer, rowing machine ergometer, stepper device; physiotherapy and rehabilitation equipment, namely, shoulder stretcher using resistance cables, treadmills, stepper, and indoor bicycles; apparatus for the therapeutic stimulation of the muscles, including the heart muscle by applying electrodes on the chest; body rehabilitation apparatus for medical purposes, namely, cardio training devices

Measuring, detecting and monitoring instruments, indicators and controllers for measuring, detecting, and monitoring electrical, physiological and chemical properties of biological organism, including a human or an animal for scientific research uses; automatic dosage apparatus, namely, machines for dispensing pre-determined dosages of medication, namely, medical drugs, blood or blood substitute for influencing physiological and chemical blood properties; electronic indicator panels for indicating body activity and function of a human or an animal; electric monitoring units for monitoring body activities of a human or an animal for scientific research uses; electric monitoring control apparatus for monitoring and controlling body activity and function of a human or an animal, including cardiac activity for scientific research uses

Investigation and surveillance services relating to the physical safety of persons and security of tangible property

Medical and veterinary preparations and articles, namely, for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest or stroke, and for resuscitation; pharmaceuticals and natural remedies for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest or stroke, and for the purpose of resuscitation; diagnostic preparations for medical and veterinary use for detecting physiological and blood-specific properties of a human or an animal; medical dressings, medical coverings and medical applicators for cover and reseal of wounds and applicators prefilled with medical drugs for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest or stroke, in particular for resuscitation and or blood for medical use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest or stroke, in particular for resuscitation or blood substitute for medical use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest or stroke, in particular for resuscitation; medicines for veterinary purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest or stroke, and resuscitation; biological preparations for medical purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest or stroke, and for resuscitation; biological preparations for veterinary and medical purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest or stroke, and for resuscitation; blood for medical purposes; blood components for medical purposes for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest or stroke, and for resuscitation; blood substitutes for medical and veterinary use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest or stroke, and for resuscitation; blood plasma; enzymes for veterinary purposes; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; solid oxygen for medical use; gases for medical purposes; gas mixtures for medical use; haemoglobin; cooling sprays for medical purposes; pharmaceutical preparations for veterinary use for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest or stroke, and for resuscitation; radioactive substances for medical purposes; solidified gases for medical purposes; veterinary preparations for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest or stroke, and for resuscitation

Filing History

POST REGISTRATION ACTION MAILED - SEC.71
Nov 19, 2025 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 28, 2025 APRE
TEAS SECTION 71 RECEIVED
May 5, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 5, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 3, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 11, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 10, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 5, 2020 FICR
NOTIFICATION PROCESSED BY IB
Jul 3, 2020 GPNX
REGISTERED-PRINCIPAL REGISTER
May 5, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 18, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 18, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 29, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 29, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 29, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 10, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 7, 2020 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 1, 2019 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 16, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 16, 2019 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 10, 2019 GNFN
FINAL REFUSAL E-MAILED
Jul 10, 2019 GNFR
FINAL REFUSAL WRITTEN
Jul 10, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2019 CRFA
ASSIGNED TO LIE
Jun 4, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 30, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2018 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2018 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 22, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 21, 2018 TROA
REFUSAL PROCESSED BY IB
Jun 9, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 22, 2018 RFCS
REFUSAL PROCESSED BY MPU
May 22, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 19, 2018 RFCR
NON-FINAL ACTION WRITTEN
May 18, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
May 15, 2018 MAFR
ASSIGNED TO EXAMINER
May 11, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 10, 2018 REPR